Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment : a National Prescription registry study. / Abrahamsen, B; Rubin, Katrine Hass; Eiken, Pia Agnete; Eastell, R.

In: Osteoporosis International, Vol. 24, No. 1, 2013, p. 321-8.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Abrahamsen, B, Rubin, KH, Eiken, PA & Eastell, R 2013, 'Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study', Osteoporosis International, vol. 24, no. 1, pp. 321-8. https://doi.org/10.1007/s00198-012-2184-6

APA

Abrahamsen, B., Rubin, K. H., Eiken, P. A., & Eastell, R. (2013). Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study. Osteoporosis International, 24(1), 321-8. https://doi.org/10.1007/s00198-012-2184-6

Vancouver

Abrahamsen B, Rubin KH, Eiken PA, Eastell R. Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study. Osteoporosis International. 2013;24(1):321-8. https://doi.org/10.1007/s00198-012-2184-6

Author

Abrahamsen, B ; Rubin, Katrine Hass ; Eiken, Pia Agnete ; Eastell, R. / Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment : a National Prescription registry study. In: Osteoporosis International. 2013 ; Vol. 24, No. 1. pp. 321-8.

Bibtex

@article{d4738b07039a4a39b50b33563beb2822,
title = "Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study",
abstract = "Antiresorptive treatment reduces the risk of fractures, but most patients remain at elevated risk. We used health registers to identify predictors of new major osteoporotic fractures in patients adhering to alendronate. Risk factors showed a different pattern than in the general population and included dementia, ulcer disease, and Parkinson's disease.",
author = "B Abrahamsen and Rubin, {Katrine Hass} and Eiken, {Pia Agnete} and R Eastell",
year = "2013",
doi = "10.1007/s00198-012-2184-6",
language = "English",
volume = "24",
pages = "321--8",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer",
number = "1",

}

RIS

TY - JOUR

T1 - Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment

T2 - a National Prescription registry study

AU - Abrahamsen, B

AU - Rubin, Katrine Hass

AU - Eiken, Pia Agnete

AU - Eastell, R

PY - 2013

Y1 - 2013

N2 - Antiresorptive treatment reduces the risk of fractures, but most patients remain at elevated risk. We used health registers to identify predictors of new major osteoporotic fractures in patients adhering to alendronate. Risk factors showed a different pattern than in the general population and included dementia, ulcer disease, and Parkinson's disease.

AB - Antiresorptive treatment reduces the risk of fractures, but most patients remain at elevated risk. We used health registers to identify predictors of new major osteoporotic fractures in patients adhering to alendronate. Risk factors showed a different pattern than in the general population and included dementia, ulcer disease, and Parkinson's disease.

U2 - 10.1007/s00198-012-2184-6

DO - 10.1007/s00198-012-2184-6

M3 - Journal article

C2 - 23070480

VL - 24

SP - 321

EP - 328

JO - Osteoporosis International

JF - Osteoporosis International

SN - 0937-941X

IS - 1

ER -

ID: 48413673